Hyperthermia is the fifth option for cancer therapeutic treatment following surgery,radiotherapy,chemotherapy and biotherapy. Considering the nontoxic and safe properties for clinical application,hyperthermia is also recognized as the harmless "green" treatment. Recently,increasing number of hospitals adopted hyperthermia equipment and obtained favorable clinical benefits for cancer patients all over the country. In 2017,we published the first hyperthermia clinical practice guideline to improve the standardization of hyperthermia procedure and shed light on the future development in China. Based on increasing updated evidence during past two years,hyperthermia expert committee of Chinese Society of Clinical Oncology(CSCO) for the first time amended the guideline including the indication,contraindication,operation procedure and so on. It is expected that this amended consensus could increase patient care and benefit via guiding hyperthermia physicians to follow standardization.